TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Disease activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidents of resident-to-resident aggression
Endpoint domain: Adverse events/effects
Primary endpoint: reduced anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in the odds of positive drug tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of anastomotic leaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: QoR-40 score on postoperative day 2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: time to first additional analgesics request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of 25 (OH)D serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Magnitude of placebo analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Levels of CD3+, CD4+, CD4+/CD8+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: EOS apoptosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SSB purchases
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Risk of all fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-care management scores
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Heritability of tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight gain after lockdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with SBP ≥ 140 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Likelihood of publication recommendation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence VAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction in symptoms of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved therapeutic progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher mental health‐related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Preterm premature rupture of membranes prior to 34 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 30-day rates of clinical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prosthetic complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in SNOT‐22 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: closure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean times to closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nurses' skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scar cosmesis rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care and comfort score
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: weight-bearing status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of CPTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile hardness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BICLA response at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores (rest) at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores (cough) at 12 and 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nausea-vomiting incidence
Endpoint domain: Adverse events/effects
Primary endpoint: IMAR levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to vaccinate daughters for HPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccination rates in children eligible for HPV vaccination
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: MLHFQ score at 6 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first HF readmission
Endpoint domain: Mortality/survival
Primary endpoint: treatment attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average resting pupil size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: constricted pupil size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful dilated pupil examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-emergent ADAs
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment-emergent NAbs
Endpoint domain: Adverse events/effects
Primary endpoint: Attitudes toward overdose victims
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Length of catheter adjustment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PICC-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Blood bicarbonate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage Excess Body Weight Loss (EBWL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crestal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: relative carbohydrate oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: relative liver glucose oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: e-cigarette harm perceptions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Levels of neuroticism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PEOL Care Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MRI spine and sacroiliac joint inflammation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in modified Stoke Ankylosing Spondylitis Spine Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Kujala score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in IKDC score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to decannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Δ moderate asthma reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily dose of ICS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of complex reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in mean FFI‐Rs score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of omalizumab treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile of omalizumab
Endpoint domain: Adverse events/effects
Primary endpoint: lean mass increase (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative index of muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbial profile of extraradicular biofilms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conners 3‐PS Composite T‐score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pigmented patches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in pigmented macules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: strain
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Success in exclusive breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Incidence of the common cold
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of upper respiratory tract infection (URTI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower inflammatory factors levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: shorter length of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: better range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower postoperative pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduction in dietary sodium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standard deviations of grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance for ANC appointments
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Child immunisation attendance
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Prevalence of Post-Thrombotic Syndrome (PTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Prevalence of recurrent Venous Thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: decreased mental illness stigma
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: blood flow velocity of ACA, MCA, PCA, VA, BA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical recovery after emergency laparotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: median pain-free period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference between clinic and SMBP for systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean difference between clinic and SMBP for diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median percentage of days with SMBP readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relapse outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of cervical dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall operative field quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: preoperative discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Peak plasma concentration of interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AUC0-24 of interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peak plasma concentration of TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AUC0-24 of TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total maximum concentration of tedizolid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total AUC0-24 of tedizolid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-week healing rate for artificial ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Overall knowledge improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concerns decrease
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: grades and points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of SMS text messaging replies requiring staff review
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Accuracy of the Multilayer Perceptron model (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False negative rate of the model
Endpoint domain: Adverse events/effects
Primary endpoint: anti-Xa Cmax0-24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: anti-Xa Cmax25-72h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total error rate
Endpoint domain: Adverse events/effects
Primary endpoint: total work performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to muscle fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain and discomfort in the mandible
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment outcome satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SwCl concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lactate dehydrogenase (LDH) response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor recovery speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nerve recovery parameters (ENMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Power score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete sensory block at 5 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complete motor block at 15 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Response to azithromycin treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cessation of epileptic spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Observer Scar Assessment Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: team efficacy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in ACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychological birth trauma score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of pressure injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in objective binge episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistence of IgG to PCV vaccine-serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional antibody (OPA) titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-specific function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative cardiac biomarker profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptom severity scores (SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysymptomatic distress (PSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol recovery after the stressor task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: exercise-PCWP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PCWP across all exercise stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6MWD improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: restoration of radial artery pulsation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Days Alive Out of Hospital (DAOH)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: overall perfectionism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: shorter FB retrieval time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: higher technical success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: lower rate of procedure-related mucosal tear and bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: conversion to laparotomy
Endpoint domain: Adverse events/effects
Primary endpoint: stoma creation
Endpoint domain: Adverse events/effects
Primary endpoint: saliva fluoride retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sample quality for total puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of each needle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bio chemical pregnancy rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Training performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Developmental delays at 36 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of treatment continuation
Endpoint domain: Mortality/survival
Primary endpoint: Sustained safety and tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in LSBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful first-attempt intubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: MNIDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: association between baseline eos/hpf and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preservation of C-peptide AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardized movement of the patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute cognitive impairment after stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total Leucocyte Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total symptom Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: App acceptability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Primary PK endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target achievement rate (serum phosphorus level ≤6.0 mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: better elimination of flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: ability to walk and tolerate a diet sooner
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer disabilities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: TAC levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stronger compression force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women attending follow-up mammography
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: prognostic understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost to prevent 1 case of PDR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost to prevent 1 case of CI-DME with vision loss
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost/DRSS unit change
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: AD documentation completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of recurrence of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morning PEFR increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total pain dimension scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of tobacco banners per 100 m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes